WHO's Africa office and the EDCTP Association sign a five-year pact on health research and regulation
19 November 2026
The World Health Organization's Regional Office for Africa and the EDCTP Association have signed a Memorandum of Understanding to strengthen health research and regulatory capacity across the WHO African Region. EDCTP stands for the European and Developing Countries Clinical Trials Partnership. The agreement was signed by Professor Mohamed Yakub Janabi, WHO Regional Director for Africa, and Abdoulie Barry, Executive Director of the EDCTP Association, and runs for five years from 2026 to 2030. It covers the building of national research systems, including clinical trials, safety surveillance and implementation research, and the harmonisation of regulatory systems for medical products so that new treatments reach markets faster. It also sets up a platform linking research institutions with national disease control programmes, and aims to strengthen country ownership of the clinical research agenda. The African Vaccine Regulators Forum, known as AVAREF, has already set regulatory standards in the region, and the EDCTP3 Global Health programme runs until 2031.
In plain words
EDCTP European and Developing Countries Clinical Trials Partnership — A partnership that funds clinical research on poverty-related infectious diseases, mainly in sub-Saharan Africa.
AVAREF African Vaccine Regulators Forum — A WHO-supported network of African regulators that reviews vaccine and medicine trials.